# Adapting LFI for Melioidosis

> **NCT03528265** · — · COMPLETED · sponsor: **Duke University** · enrollment: 100 (actual)

## Conditions studied

- Melioidosis

## Interventions

- **DEVICE:** Lateral flow immunoassay

## Key facts

- **NCT ID:** NCT03528265
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-21
- **Primary completion:** 2019-01-08
- **Final completion:** 2019-01-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03528265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03528265, "Adapting LFI for Melioidosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03528265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*